Oncology

This page is a central location for oncology information, including CMS resources.

Spotlight

  • NCD 110.24: Chimeric Antigen Receptor (CAR) T-cell Therapy
    Effective for dates of service on or after August 7, 2019, Medicare will pay claims from approved providers for administration of autologous T-cells expressing at least one CAR for the treatment for cancer. This article was updated January 7, 2025, to update some HCPCS codes with current CPT codes for CY 2025.

Policy Information

Not all services have a policy associated with them. We will consider Reasonable and Necessary Guidelines in the absence of an LCD, billing and coding article, NCD, or CMS manual instruction that limits coverage.

LCDs

Learn more about the LCD development process through the following:

Search for oncology-related LCDs using these available resources:

NCDs

Search for oncology-related NCDs using these available tools:


Medical documentation

For a claim to be valid, documentation must demonstrate compliance with all applicable coverage, coding and billing requirements and substantiate the level of care billed. The following resources are specific to oncology but may not address all required medical documentation requirements:


Claim Submission and Reimbursement


Additional Information

CMS


Education

View our wide selection of free, live and on-demand training options:


Stay Informed

Stay updated on the latest Medicare information with free email subscriptions: